Clinical trial

Determine How Consumption of Dairy Fat as Cheese Influences Inflammation-Phase 2

Active, not recruiting · Not applicable · 1 countries · Registry ID NCT01803633

Active, not recruitingNot applicableInterventional

What this study is about

Phase 2 of this study involves determining how consumption of cheese compared with a non-dairy cheese substitute influences inflammation over a six hour period.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age18 Years to 65 Years
SexAll
Healthy volunteersAccepted
ConditionMetabolic Syndrome, Obesity

Full registry criteria

Inclusion Criteria: * Age 18-65 years * Two or more components of metabolic syndrome: Central obesity (waist circumference greater than 40 inches for men and 35 inches for women); fasting blood triglycerides greater than or equal to 150 mg/dL; plasma HDL cholesterol (Less than 40 mg/dL for men and less than 50 mg/dL for women); blood pressure greater than or equal to 130/85 mmHg; fasting glucose greater than or equal to 100 mg/dL or \- BMI equal to or greater than 30 Exclusion Criteria: Metabolic Disorders: * BMI \> 40 * Body weight more than 400 lbs. * Any immune related diseases such as autoimmune disease, rheumatoid arthritis, asthma, * Gastrointestinal disorders including Crohn's Disease, colitis, diverticulitis, irritable bowel disease, celiac, malabsorption syndrome * Cancer * Known presence of significant metabolic disease which could impact the results of the study (i.e. hepatic, renal disease) * Type II diabetes * Use of over-the-counter anti-obesity agents (e.g. containing phenylpropanolamine, ephedrine, and/or caffeine) within the last 12 weeks * Use of corticoid steroids within the last 12 weeks * Daily use of anti-inflammatory pain medication * Self report of eating disorder * Poor vein assessment determined by WHNRC's phlebotomist Dietary/supplements: * Known allergy or intolerance to study food (lactose intolerance, dairy, wheat allergies) * Vegetarian (defined as abstinence from consumption of eggs, dairy, poultry, beef and pork) * More than 1 serving of fish per week * More than 14 grams of fiber per 1000 kcal per day * Less than 16:1 of total dietary omega 6: Omega 3 ratio * More than 1% of daily energy as trans fats * Initiation of anti-inflammatory supplemental fish, krill, flax, borage and primrose seed oils within the last 12 weeks * Dietary supplements consisting of concentrated soy isoflavones, resveratrol, other polyphenols identified as modulators of inflammation Medications * Initiation of statin therapy within the last 12 weeks Lifestyle * More than 10% weight loss or gain during the past 6 months * Recent initiation (past 4 weeks) of exercise program * Plan to become pregnant in the next 6 months * Pregnancy or lactation * Recent initiation or cessation of hormonal birth control or change in hormonal birth control regimen within the last 12 weeks * Use of tobacco products * More than 2 standard alcoholic drinks per day.

Treatments and study arms

Cheddar cheese

Other

Tillamook medium cheddar cheese brand

Vegan cheese

Other

Daiya brand vegan cheese

Primary outcomes

Plasma inflammatory mediators0, 1, 3, 6 hr postprandial

Plasma cytokines will be measured using a multi-plex immunoassay and plasma oxylipins will be measured by mass spectroscopy.

Study locations

1 locations were listed when this page was built. The first 40 are shown.

USDA Western Human Nutrition Research Center🇺🇸 Davis, California, United States